The below information from the AGM Presentation today.
'Well funded to deliver value adding milestones
Best in class, unique platform.
Enviably positioned ahead of a huge wave in CAR-T
Many shots on goal for substantial value creation
Two differentiated targeted therapies in clinical trials, each a potential company-maker
Creating next generation CAR-T products for Prescient
Earlier monetisation opportunities as an enabling technology for 3rd parties.'
Strong cash position to top the great news off.
When I compare this to MSB as an example, I see HUGE upside for this stock.
Add to My Watchlist
What is My Watchlist?
